Intervention
HRS9531 injection
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 8 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
8 shownA Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With ObesityNCT07285902 · 2025-12-25
ACTIVE_NOT_RECRUITINGThe Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection SolutionNCT06792955 · 2025-02-11
COMPLETEDA Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy SubjectsNCT06762600 · 2025-01-16
COMPLETEDInfluence of HRS9531 on Pharmacokinetics of Metformin in Healthy SubjectsNCT06654960 · 2024-11-05
COMPLETEDTo Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or ObeseNCT06396429 · 2024-05-13
COMPLETEDEfficacy and Safety of HRS9531 Injections in Overweight or Obese SubjectsNCT06054698 · 2023-10-16
COMPLETEDEfficacy and Safety of HRS9531 Injection in Type 2 Diabetes SubjectsNCT05966272 · 2023-08-12
COMPLETEDEfficacy and Safety of HRS9531 Injection in Obese Subjects Without DiabetesNCT05881837 · 2023-06-13
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED7
ACTIVE_NOT_RECRUITING1
Phase mix
PHASE13
PHASE23
PHASE32
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.